Warriors Hearts Founders L to R: Josh Lannon, Lisa Lannon, Tom Spooner at their addiction and PTSD treatment center outside San Antonio, Texas

This 1000 warriors’ milestone is a major achievement; and there are many more warriors who are still suffering that earned our help. From 9/11 to a 911 call, Warriors Heart takes pride in caring for those who take care of us. – Josh Lannon, Warriors Heart CEO and Founder

SAN ANTONIO (PRWEB)
July 01, 2020

With a bold Mission to “Bring 1 Million Warriors Home”, Warriors Heart celebrates 1000 clients that have entered their healing programs since their grand opening four years ago. During this week, Warriors Heart will showcase many aspects of their addiction and PTSD treatment programs on their social media channels, including a Special Facebook Live Townhall this Thursday, July 2, 2020, at 6pm EST, with the 3 Founders, Josh Lannon, Lisa Lannon, and Tom Spooner.

CEO and Founder Josh Lannon shared, “This 1000 warriors’ milestone is a major achievement, and there are many more warriors who are still suffering that earned our help. We are committed to the long war. From 9/11 to a 911 call, Warriors Heart takes pride in caring for those who take care of us. As the first and only private and accredited treatment program in the United States for “warriors only,” our focus is to exclusively serve adult men and women veterans, active duty military, US law enforcement, firefighters, paramedics and first responders.”

Based on a 543-acre ranch outside San Antonio, Texas, Warriors Heart specializes in substance abuse treatment and co-occurring psychological disorders with acute attention to post-traumatic stress, unresolved grief/loss, and moral injury. The treatment courses provide the full continuum of care, from detox, inpatient (residential), day treatment, outpatient, sober living, and 1-on-1 counseling.

Former Special Forces and Warriors Heart Founder Tom Spooner is proud to have developed a peer-to-peer training program model with the team so veterans and first responders can relate with each other’s experiences. This training program approach structures participants’ recovery with daily activities. The first activity is breakfast or “chow,” followed by physical training (nature hike, yoga, and jiu jitsu), evidence-based group therapy and individual therapy, K9 program, fishing, a metal and wood shop, and more.

With gratitude, Warriors Heart Founder Lisa Lannon emphasized, “We couldn’t do this without the efforts of our amazing team and all the relationships we have with other organizations and individuals. To hear our Warriors say, “Thank you for giving me my life back, there is nothing like this out there for us,” tells us we are doing the right thing for the right reasons.”

And with Warriors Heart’s recent launch of the new W.A. (Warriors Anonymous) 12-step specialty program for “warriors only” on the frontline based on A.A. (Alcoholics Anonymous) that anyone can set up, the team is expanding their “Strength Through Healing” reach.

Media Contact for Warriors Heart:

Liz Kelly, 310-987-7207

About Warriors Heart (Bandera, Texas right outside San Antonio):

Warriors Heart is the first and only private accredited treatment program in the U.S. for “Warriors Only” (military, veterans and first responders) faced with the self-medicating struggles of alcohol, prescription and/or drug addiction, PTSD (post-traumatic stress disorder), mild TBI (Traumatic Brain Injury) and other recurring issues. It’s a private, 60-bed facility on a 543-acre ranch founded by Josh Lannon (successful treatment provider in long-term recovery), Lisa Lannon (Former Law Enforcement Officer) and Tom Spooner (Former Army Special Operations). Along with a 42-day residential treatment program, Warriors Heart provides “Warriors” detox, inpatient, Intensive Outpatient, Telehealth Outpatient, and Sober Living. Warriors Heart has been operational since April 2016, and officially received the Gold Seal of Approval® for Behavioral Health Care Accreditation in November 2016 and re-accredited in August 2019. Warriors Heart’s work has been featured on the TODAY Show, CBS Health Watch, KENS5 CBS San Antonio, FOX 11 Los Angeles, FOX 10 Phoenix, and in TIME, Forbes, The Chicago Tribune, The American Legion Magazine, Addiction Pro, San Antonio Express-News, PoliceOne and many more. There is a 24-hour Warriors Heart hotline (844-448-2567). https://www.warriorsheart.com

Share article on social media or email:

“We named this new brand Danisco Planit™ as an acknowledgement that when scaling up this industry it must happen in a sustainable way,” explains Birgitte Borch, VP of Marketing, Food & Beverage, DuPont Nutrition & Biosciences.

COPENHAGEN, Denmark (PRWEB)
July 01, 2020

Danisco Planit™ marks the latest evolution in DuPont’s plant-based ingredient portfolio – a comprehensive range of functional ingredients and application expertise for food and beverages made with a ‘planet forward,’ sustainable approach.

With the new Danisco Planit™ range, DuPont Nutrition & Biosciences (DuPont) offers food and beverage manufacturers the broadest selection of ingredients for plant-based product development in the industry, supported by expert application knowledge and insights to design products for the future. Customers leveraging DuPont’s innovation capabilities in the plant-based segment will be ahead of the curve in managing their global footprint.

“We named this new brand Danisco Planit™ as an acknowledgement that when scaling up this industry it must happen in a sustainable way,” explains Birgitte Borch, VP of Marketing, Food & Beverage, DuPont Nutrition & Biosciences.

DuPont has decades of experience in the plant-based sector, providing support in every step from conceptualization to successful commercialization of innovative, yet locally relevant solutions and recipes that are ready to take to market.

“The depth of what we can offer our customers is unique in the industry,” Borch said. “Danisco Planit™ is a significant launch for us. We offer a total ingredient solution with the ability to deliver taste, texture, nutrition and sustainability. And, we believe in co-creation and look forward to innovating new formats and categories with our customers to widen the food space and create great eating experiences for the growing group of global consumers that want to increase their plant-based consumption.”

Capturing mainstream consumers

For the past couple of years, the plant-based space has been a race to get on the shelves for both foodservice and retailers. Now it’s about staying there and growing further by offering a greater variety of categories.

“The market innovation for products that allow consumers to eat a burger without eating meat, drink a milkshake without drinking milk, have been impressive,” Borch said. “For the mass market consumer however, we want to do more. Mainstream consumers are not only looking to avoid meat or dairy, they are looking for a great eating experience. In order to take plant-based mainstream, we need to expand innovation beyond imitation. We want to support the shift to a more plant-based diet by creating multiple options, thereby enabling nutritious, plant-based food and beverages in every meal, every day—from early-bird breakfast to the midnight snack.”

Borch sees plant-based as an opportunity for the industry to meet consumers’ changing eating habits.

“We believe co-creation is the route to shape the market and capture fast-evolving consumer needs for every eating occasion,” Borch said. “We want to create sustainable consumer loyalty, ensuring that plant-based products are loved and tasty enough to become a regular part of consumers’ diets, not just a ‘try it once’.”

Plant-in-it is key

In plant-based products, as in all food categories, taste and texture are imperative. However, in plant-based there are a variety of protein sources, and when combined with consumer requirements for health and nutrition, designing and formulating new formats that are top-performing in all sensory dimensions is a challenge. A great tasting product isn’t just about flavor, but the interactivity among sight, smell, touch and sound. Sensory expertise is at the center of new product development for plant-based food and beverages.

“We can turn our insights into business opportunities and forge a new product development pipeline with formulation strategies that maximize consumer liking and meet the requirements on nutrition and ingredient lists,” said Sonia Huppert, Global Marketing Lead for Plant-based Health. “We keep a constant focus on developing ingredient solutions for new products, and for plant-based food and beverages in particular, to offer to the plant-based industry innovative solutions for plant-based yogurt, ice cream, drink, and meat alternatives, including full meal solutions.”

Danisco Planit™ has been launched globally and covers services, expertise, and an unmatched ingredient portfolio for plant-based food and beverages: plant proteins, hydrocolloids, cultures, probiotics, fibers, food protection, antioxidants, natural extracts, emulsifiers, and enzymes, as well as tailor-made systems. For more information: http://www.food.dupont.com

About DuPont™ Danisco®

DuPont™ Danisco® is the brand for a range of ingredients that help provide enhanced bioprotection, an improved nutritional profile, and better taste and texture with greater cost efficiency and lower environmental impact, meeting the needs of manufacturers of food and beverages, dietary supplements and pet food. Through the work of the global network of food scientists and technologists in DuPont, the Danisco® range is supported by a uniquely broad spectrum of know-how across applications and processing. http://www.danisco.com.

About DuPont Nutrition & Biosciences

DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com or http://www.biosciences.dupont.com/

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com/.

# # #

01/07/2020

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

For further information contact:

Jette Westerdahl

+45 2830 7684

Jette.Westerdahl@dupont.com

WCG FDAnews

FALLS CHURCH, Va. (PRWEB)
July 01, 2020

What impact do statistical techniques have on design control process?

How can one best address sample size issues?

Design control statistical expert Steve Walfish is here with a set of tools to help attendees understand statistical sampling plans.

Mr. Walfish will develop a framework for statistical justification where one will:

• 
  Appreciate the nuanced interpretations of 21 CFR 820.250
• Recognize the differences between confidence and reliability in the sample size
• Address actual issues faced by medical device companies through case studies
• Understand the importance of how data is collected and how to justify the sample size
• Incorporate statistical assumptions, such as independence, as part of all sampling plans
• Grasp how variance in the population impacts the sample size necessary to establish objective evidence

Take control of sample size issues! Learn how to use sound risk management techniques in combination with statistical methods and reduce sample sizes.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

How to Address Medical Device Sample Size Issues:

What Regulatory and Quality Professionals Absolutely Must Know

An FDAnews Webinar

Wednesday, July 15, 2020, 1:30-3:00 p.m. EDT

https://www.fdanews.com/mdsamplesize

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/mdsamplesize

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

WCG FDANews

FALLS CHURCH, Va. (PRWEB)
June 30, 2020

EU-MDR Postmarket Surveillance:

Best Practices for Medical Device Regulatory, Compliance & Quality Specialists

An FDAnews Webinar

Tuesday, July 14, 2020, 1:30-3:00 p.m. EDT

https://www.fdanews.com/eumdrpostmarket

Prepare for EU-MDR postmarket surveillance (PMS) requirements and its detailed product-specific plans and reports.

With greater emphasis on confirming safety and performance throughout a device’s lifetime, one needs to be more proactive with one’s postmarket activities than before, including the postmarket clinical follow-up (PMCF).

Plus, to ensure alignment, all the data collected needs to be considered in a clinical evaluation report (CER), risk management documents and labeling. Learn to do this with maximum efficiency.

Jon Gimbel, Ph.D., will explain the best practices needed to easily create — and keep up to date — product-specific plans and reports to stay compliant. He’ll explain how these activities are all related, enabling one to improve efficiency throughout the organization:

• Details on the specific data elements that should be included in the Postmarket Surveillance Report (PMSR), Periodic Safety Update Report (PSUR), PMCF report and CER and how the data from various reports can be linked together.
• An overview of an example process that will enable the PMS, PMCF, CER and risks management documentation to be linked and updated together.
• An explanation of how proactive PMS is related to PMS and PMCF and what type of activities are considered PMS vs. PMCF.
• An understanding of the type of objectives of PMCF, such as to confirm safety and performance throughout the lifetime of the device and not to provide sufficient clinical evidence to demonstrate conformity to the applicable General Safety Performance Requirements (GSPRs).
• A discussion of common findings related to PMS and PMCF, such as failure to provide a statistically justified sample size.

Easily master postmarket surveillance and confirm the safety and performance throughout the lifetime of one’s medical device. Be ready by the May 2021 deadline

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Webinar Details:

EU-MDR Postmarket Surveillance:

Best Practices for Medical Device Regulatory, Compliance & Quality Specialists

An FDAnews Webinar

Tuesday, July 14, 2020, 1:30-3:00 p.m. EDT

https://www.fdanews.com/eumdrpostmarket

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/eumdrpostmarket

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

“In our own practice and research, we find that a more affirming approach to care reduces stigma.”

BOSTON (PRWEB)
June 30, 2020

An editorial published in The British Journal of Psychiatry calls for the development of alternative psychiatric care frameworks that affirm transgender and gender-diverse (TGD) people without pathologizing them through clinical diagnoses. The editorial was authored by researchers at The Fenway Institute and Dartmouth-Hitchcock Medical Center and adds to a growing body of literature demonstrating the need to uncouple gender diversity from the stigma of diagnostic classification.

“In our own practice and research, we find that a more affirming approach to care reduces stigma,” said editorial co-author Alex Keuroghlian, MD, MPH, Director of Education and Training Programs at The Fenway Institute. “Our field has a duty to validate diverse gender identities without assuming pathology.”

The editorial asserts that the field should be asking critical questions as it creates alternative psychiatric care frameworks that affirm TGD people. These include the following:

• Why is a specific diagnosis needed for a child struggling with questions related to their gender identity, but not their sexual orientation?
• What is the value in assigning a diagnosis to a patient with no immediate medical needs when description of a specific service code such as “gender-affirming” counseling would suffice?
• How can psychiatry deliver gender-affirming care for TGD people who do not endorse gender-related dysphoria?
• Can psychiatry understand experiences of gender diversity without an assumption of distress or pathology?

The editorial notes that the requirement by many third-party payers for a diagnosis code for health care reimbursement is currently driving the requirement for psychiatric assessment before any gender-affirming care can be delivered, and that formal diagnoses often protect patients against denials of coverage. It also notes that the requirement for psychiatric evaluation prior to gender-affirming surgical care is widely misunderstood as a threshold test to determine whether a patient is sufficiently gender dysphoric to warrant surgical intervention. Instead, psychiatric evaluation is needed before gender-affirming surgical care to ensure that patients are connected to wellness services during a potentially stressful period of personal change.

“The inclusion, revision, and subsequent removal of homosexuality in successive editions of the DSM is illustrative of how our conceptions of gender identity may evolve,” added Keuroghlian. “Sexual minority people with major depressive disorder and substance use disorders are treated for these problems without need for a sexual minority-specific diagnostic code. At this point, we think psychiatry needs to look critically at the central role now played by the DSM in understanding TGD people.”

Read the full editorial here.

Since 1971, Fenway Health has been working to make life healthier for the people in our neighborhoods, the LGBTQ community, people living with HIV/AIDS and the broader population. The Fenway Institute at Fenway Health is an interdisciplinary center for research, training, education and policy development focusing on national and international health issues.

Share article on social media or email:

UNA-Test bundles competency exams, skills checklists, and annual mandatories into a single, easy-to-use mobile platform that caters to end users and staffing professionals alike.

MIAMI (PRWEB)
June 30, 2020

UNA Health Inc – a leading provider of mobile recruitment, onboarding, and testing solutions for hospitals and healthcare staffing firms – will soon release its flagship product UNA-Test, the world’s first mobile competency testing platform for the healthcare staffing industry. Created by the former CEO and Founder of Prophecy Healthcare Testing, Ron Gonzalez, UNA-Test addresses the biggest drawbacks of traditional validation methodologies.

“UNA-Test bundles competency exams, skills checklists, and annual mandatories into a single, easy-to-use mobile platform that caters to end users and staffing professionals alike,” said Ron Gonzalez, CEO of UNA Health. “It shortens the time professionals spend on the applicant screening that’s used to determine their baseline minimum competency, without compromising on quality, and still adhering to Joint Commission standards for competency evaluation.”

UNA-Test was developed using a proprietary Expert Validation Protocol™, which focuses on the most critical aspects of job duties, knowledge, skills, and abilities required of a healthcare professional. This EVP methodology is superior to traditional testing because it uses highly-focused critical thinking scenarios to discern the critical thinking skills of the candidate. All test items are reviewed by a panel of subject matter experts for fairness, difficulty level, and importance to the job by using best-in-class validation software, and results are available immediately to both healthcare professionals and their employers.

And because of the platform’s portability, UNA users can complete skills tests at their leisure, as well as start and stop as many times as they wish. On average, skills checklists can now be completed in 50% less time than traditional competency and frequency checklists.

“Our assessments are more focused and can better determine if a professional demonstrates the minimal level of competency required to deliver safe and effective patient care,” added Rich Benvenuto, Chief Relationship Officer of UNA Health. “The end result is quicker turn times, more accurate results, and faster placements.”

About UNA Health Inc

UNA Health Inc is a leading provider of mobile recruitment solutions for hospitals and healthcare staffing firms. The UNA platform of fully customizable mobile solutions includes engaging onboarding tools, competency testing, skills checklists, annual competencies, credential management and position notifications – all in one client branded app. The platform seamlessly integrates with applicant tracking systems and hospital H.R. software, and provides end users with a truly mobile experience and the ability to effortlessly apply for positions with one-click, as well as upload credentials into our proprietary credential management portal.

UNA streamlines the hiring and credentialing process, and saves both recruiters and Q.A. teams worker hours, which translates into increased efficiencies, and ultimately, cost savings.

For more information, contact Ronald Gonzalez at ron@unahealth.co or 866-UNA-HLTH, 866-862-4584.

Share article on social media or email:

Steven Svehlak and Dr. Dan Yamini have three cornerstones to their practice, they constantly try to nurture: patient satisfaction, comfort, and, above all, safety

LOS ANGELES (PRWEB)
June 30, 2020

Haute Beauty Welcomes Dr. Dan Yamini and Dr. Steven Svehlak! Rated two of Southern California’s leading Board-certified plastic surgeons, opening Sunset Cosmetic Surgery in the Los Angeles area, for over the past six years. They are renowned for their skills and capabilities to help you achieve your dreams.

Visit their website at: https://www.sunsetcosmeticsurgery.com/

Dr. Dan Yamini

Dr. Dan Yamini was accepted to the Providence Hospital Plastic Surgery Program in Michigan. His training was led by the world-renowned Dr. Ian Thomas Jackson at the Craniofacial Institute. Dr. Jackson, who was the head of plastic surgery at the Mayo Clinic, is considered one of the true “Fathers” of plastic surgery. Dr. Dan Yamini has been invited to present his work in cosmetic surgery techniques at the premier international cosmetic conference (ASAPS) multiple times.

Dr. Dan Yamini pursued an advanced fellowship in facial and body cosmetic surgery with one of the most experienced and renowned cosmetic surgeons in the world. Dr. Yamini has earned the recognition as one of “America’s Top Surgeons,” as well as a Patient’s Choice Award.

There are three cornerstones to his practice which Dr. Dan Yamani is proud of, and constantly tries to nurture: patient satisfaction, comfort, and, above all, safety.

Dr. Steven Svehlak

Dr. Svehlak sought plastic surgeon with a passion, did his raining and completed an intense and highly competitive plastic surgery program at George Washington University in Washington, D.C., in 2001. He learned the techniques of reconstructive surgery, including those applied in cancer, breast, and trauma surgeries. Dr. Svehlak gained additional training at Children’s National Medical Center in Washington, D.C., where he focused on facial reconstructive surgery, including cleft lip and palate. He also became quite experienced in treating many types of congenital hand deformities.

In 2002, Dr. Steven Svehlak was offered an Advanced Aesthetic Fellowship in Beverly Hills, California. Dr. Svehlak worked side by side with a 30-year veteran of plastic surgery, performing rhinoplasty, breast augmentations and reductions, liposuction, and facial surgery. He became very knowledgeable in the art of cosmetic surgery and developed a keen eye in aesthetics.

Dr. Steven Svehlak has been featured in the Consumers’ Research Council of America’s Guide to America’s Top Plastic Surgeons for the past six years

About Haute Beauty:

Haute Beauty offers readers access to an invite-only, prominent collective of leading doctors and industry-leading aesthetic surgeons located in their area. Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed surgeons.

For more about Haute Beauty, please visit http://www.hauteliving.com/hautebeauty

Share article on social media or email: